Israel - engelska - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).

Irland - engelska - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - ceftazidime - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; ceftazidime

Irland - engelska - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - ceftazidime - powder for solution for injection/infusion - 2 gram(s) - third-generation cephalosporins; ceftazidime

Kanada - engelska - Health Canada

fresenius kabi canada ltd - ceftazidime - powder for solution - 1g - ceftazidime 1g - third generation cephalosporins

Kanada - engelska - Health Canada

fresenius kabi canada ltd - ceftazidime - powder for solution - 6g - ceftazidime 6g - third generation cephalosporins

Kanada - engelska - Health Canada

fresenius kabi canada ltd - ceftazidime - powder for solution - 2g - ceftazidime 2g - third generation cephalosporins

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - avibactam sodium, quantity: 543.5 mg (equivalent: avibactam, qty 500 mg); ceftazidime pentahydrate, quantity: 2329.7 mg (equivalent: ceftazidime, qty 2000 mg) - injection, powder for - excipient ingredients: sodium carbonate - zavicefta is indicated for the treatment of the following infections in adults (see sections 4.4 special warnings and precautions for use and 5.1 pharmacodynamic properties):,? complicated intra-abdominal infection (ciai) in combination with metronidazole. ? complicated urinary tract infection (cuti) including pyelonephritis.,? hospital-acquired pneumonia (hap) including ventilator associated pneumonia (vap).,zavicefta is indicated for the treatment of the following infections in infants and paediatric patients (greater than or equal to 3 months to < 18 years) (see sections 4.4 special warnings and precautions for use and 5.1 pharmacodynamic properties):,? complicated intra-abdominal infection (ciai) in combination with metronidazole. ? complicated urinary tract infection (cuti) including pyelonephritis.,consideration should be given to official guidance on the appropriate use of antibacterial agents.,to reduce the development of drug-resistant bacteria and maintain the effectiveness of zavicefta and other antibiotics, zavicefta should be used in combination with an antibacterial agent(s) active against gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.

USA - engelska - NLM (National Library of Medicine)

cardinal health - ceftazidime sodium (unii: cmc30v039k) (ceftazidime - unii:9m416z9qnr) - ceftazidime sodium 20 mg in 1 ml

USA - engelska - NLM (National Library of Medicine)

hospira, inc. - ceftazidime (unii: 9m416z9qnr) (ceftazidime anhydrous - unii:dzr1ent301) - ceftazidime anhydrous 6 g - tazicef (ceftazidime for injection, usp) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: tazicef (ceftazidime for injection, usp) may be used alone in cases of confirmed or suspected sepsis. ceftazidime has been used successfully in clinical trials as empiric therapy in cases where various concomitant therapies with other antibacterial drugs have been used. tazicef may also be used concomitantly with other antibacterial drugs, such as aminoglycosides, vancomycin, and clindamycin; in severe and life-threatening infections; and in the immunocompromised patient. when such concomitant treatment is appropriate, prescribing information in the labeling for the other antibacterial drugs should be followed. the dose depends on the severity of the infection and the patient's condition. to reduce the development of drug-resistant bacteria and maintain the effectiveness of tazicef (ceftazidime) and other antibacterial drugs,

USA - engelska - NLM (National Library of Medicine)

teligent pharma, inc. - ceftazidime (unii: 9m416z9qnr) (ceftazidime anhydrous - unii:dzr1ent301) - ceftazidime anhydrous 200 mg in 1 ml - fortaz is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: fortaz may be used alone in cases of confirmed or suspected sepsis. ceftazidime has been used successfully in clinical trials as empiric therapy in cases where various concomitant therapies with other antibacterial drugs have been used. fortaz may also be used concomitantly with other antibacterial drugs, such as aminoglycosides, vancomycin, and clindamycin; in severe and life-threatening infections; and in the immunocompromised patient. when such concomitant treatment is appropriate, prescribing information in the labeling for the other antibacterial drugs should be followed. the dose depends on the severity of the infection and the patient's condition. to reduce the development of drug-resistant bacteria and maintain the effectiveness of fortaz and other antibacterial drugs, fortaz should be used only to treat infections that are proven or strongly suspected